» Articles » PMID: 27526664

Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I/A-II HDL Particles in Human Plasma

Overview
Journal Sci Rep
Specialty Science
Date 2016 Aug 17
PMID 27526664
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Plasma concentration of apoA-I, apoA-II and apoA-II-unassociated apoA-I was analyzed in 314 Japanese subjects (177 males and 137 females), including one (male) homozygote and 37 (20 males and 17 females) heterozygotes of genetic CETP deficiency. ApoA-I unassociated with apoA-II markedly and linearly increased with HDL-cholesterol, while apoA-II increased only very slightly and the ratio of apoA-II-associated apoA-I to apoA-II stayed constant at 2 in molar ratio throughout the increase of HDL-cholesterol, among the wild type and heterozygous CETP deficiency. Thus, overall HDL concentration almost exclusively depends on HDL with apoA-I without apoA-II (LpAI) while concentration of HDL containing apoA-I and apoA-II (LpAI:AII) is constant having a fixed molar ratio of 2 : 1 regardless of total HDL and apoA-I concentration. Distribution of apoA-I between LpAI and LpAI:AII is consistent with a model of statistical partitioning regardless of sex and CETP genotype. The analysis also indicated that LpA-I accommodates on average 4 apoA-I molecules and has a clearance rate indistinguishable from LpAI:AII. Independent evidence indicated LpAI:A-II has a diameter 20% smaller than LpAI, consistent with a model having two apoA-I and one apoA-II. The functional contribution of these particles is to be investigated.

Citing Articles

Closing the gaps in patient management of dyslipidemia: stepping into cardiovascular precision diagnostics with apolipoprotein profiling.

Reijnders E, van der Laarse A, Ruhaak L, Cobbaert C Clin Proteomics. 2024; 21(1):19.

PMID: 38429638 PMC: 10908091. DOI: 10.1186/s12014-024-09465-w.


Enhancement of High-Density Lipoprotein (HDL) Quantity and Quality by Regular and Habitual Exercise in Middle-Aged Women with Improvements in Lipid and Apolipoprotein Profiles: Larger Particle Size and Higher Antioxidant Ability of HDL.

Cho K, Nam H, Kang D, Zee S, Park M Int J Mol Sci. 2023; 24(2).

PMID: 36674667 PMC: 9862890. DOI: 10.3390/ijms24021151.


Continuous and Marked Increase of Japanese HDL Associates Paradoxically with their Nutritional Shift.

Yokoyama S J Atheroscler Thromb. 2022; 30(8):919-933.

PMID: 36384911 PMC: 10406630. DOI: 10.5551/jat.63894.


HDL-apoA-II Is Strongly Associated with 1-Year Mortality in Acute Heart Failure Patients.

Klobucar I, Degoricija V, Potocnjak I, Trbusic M, Pregartner G, Berghold A Biomedicines. 2022; 10(7).

PMID: 35884971 PMC: 9313377. DOI: 10.3390/biomedicines10071668.


Apolipoprotein A-II, a Player in Multiple Processes and Diseases.

Florea G, Tudorache I, Fuior E, Ionita R, Dumitrescu M, Fenyo I Biomedicines. 2022; 10(7).

PMID: 35884883 PMC: 9313276. DOI: 10.3390/biomedicines10071578.


References
1.
Ohta T, Nakamura R, Takata K, Saito Y, Yamashita S, Horiuchi S . Structural and functional differences of subspecies of apoA-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency. J Lipid Res. 1995; 36(4):696-704. View

2.
Lux S, John K, BREWER Jr H . Isolation and characterization of apoLp-Gln-II (apoA-II), a plasma high density apolipoprotein containing two identical polypeptide chains. J Biol Chem. 1972; 247(23):7510-8. View

3.
Cheung M, Albers J . Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II. J Lipid Res. 1982; 23(5):747-53. View

4.
Gordon S, Deng J, Lu L, Davidson W . Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography. J Proteome Res. 2010; 9(10):5239-49. PMC: 3100175. DOI: 10.1021/pr100520x. View

5.
Ohnishi T, Yokoyama S . Activation of human plasma lipid transfer protein by apolipoproteins. Biochemistry. 1993; 32(19):5029-35. DOI: 10.1021/bi00070a009. View